Seals DR, Justice JN, LaRocca TJ. Physiological geroscience: targeting function to increase healthspan and achieve optimal longevity. J Physiol. 2016;594(8):2001-2024.
DOI: 10.1113/jphysiol.2014.282665
United Nations. Envejecimiento [Internet]. Naciones Unidas. 2019 [citado 20 de marzo de 2022]. Recuperado a partir de: https://www.un.org/es/global-issues/ageing
Song S, Lam EW, Tchkonia T, Kirkland JL, Sun Y. Senescent Cells: Emerging Targets for Human Aging and Age-Related Diseases. Trends Biochem Sci. 2020;45(7):578-592.
DOI: 10.1016/j.tibs.2020.03.008
Khosla S, Farr JN, Tchkonia T, Kirkland JL. The role of cellular senescence in ageing and endocrine disease. Nat Rev Endocrinol. 2020;16(5):263-275.
DOI: 10.1038/s41574-020-0335-y
Tchkonia T, Zhu Y, van Deursen J, Campisi J, Kirkland JL. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest. 2013;123(3): 966-972.
DOI: 10.1172/JCI64098
Kirkland JL, Stout MB, Sierra F. Resilience in Aging Mice. J Gerontol A Biol Sci Med Sci. 2016;71(11):1407-1414.
DOI: 10.1093/gerona/glw086
Kennedy BK, Berger SL, Brunet A, Campisi J, Cuervo AM, Epel ES, et al. Geroscience: linking aging to chronic disease. Cell. 2014;159(4):709-713.
DOI: 10.1016/j.cell.2014.10.039
Kirkland JL, Tchkonia T. Senolytic drugs: from discovery to translation. J Intern Med. 2020;288(5):518-536.
DOI: 10.1111/joim.13141
Galiana Guillem I, Martínez Máñez R (dir), Orzáez Calatayud M (dir). Desarrollo de nuevos nanodispositivos terapéuticos aplicados al tratamiento de enfermedades relacionadas con procesos de senescencia [tesis doctoral en Internet]. [Valencia]: Universitat Politèctica de València; 2020 [citado 15 marzo de 2022]. Recuperado a partir de: http://hdl.handle.net/10251/151950
Demaria M, Ohtani N, Youssef SA, Rodier F, Toussaint W, Mitchell JR, et al. An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev Cell. 2014;31(6):722-733.
DOI: 10.1016/j.devcel.2014.11.012
Lagoumtzi SM, Chondrogianni N. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases. Free Radic Biol Med. 2021;171:169-190.
DOI: 10.1016/j.freeradbiomed.2021.05.003
Tchkonia T, Palmer AK, Kirkland JL. New Horizons: Novel Approaches to Enhance Healthspan Through Targeting Cellular Senescence and Related Aging Mechanisms. J Clin Endocrinol Metab. 2021;106(3):e1481-e1487.
DOI: 10.1210/clinem/dgaa728
DeVito LM, Barzilai N, Cuervo AM, Niedernhofer LJ, Milman S, Levine M, et al. Extending human healthspan and longevity: a symposium report. Ann N Y Acad Sci. 2022;1507(1):70-83.
DOI: 10.1111/nyas.14681
Gorgoulis V, Adams PD, Alimonti A, Bennett DC, Bischof O, Bishop C, et al. Cellular Senescence: Defining a Path Forward. Cell. 2019;179(4):813-827.
DOI: 10.1016/j.cell.2019.10.005
Zhu Y, Tchkonia T, Pirtskhalava T, Gower AC, Ding H, Giorgadze N, et al. The Achilles' heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell. 2015;14(4):644-658.
DOI: 10.1111/acel.12344
Kirkland JL, Tchkonia T, Zhu Y, Niedernhofer LJ, Robbins PD. The Clinical Potential of Senolytic Drugs. J Am Geriatr Soc. 2017;65(10):2297-2301.
DOI: 10.1111/jgs.14969
Xu M, Bradley EW, Weivoda MM, Hwang SM, Pirtskhalava T, Decklever T, et al. Transplanted Senescent Cells Induce an Osteoarthritis-Like Condition in Mice. J Gerontol A Biol Sci Med Sci. 2017;72(6):780-785.
Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B, et al. Clearance of p16lnk4a-positive senescent cell delays ageing-associated disorders. Nature. 2011;479(7372):232-236.
DOI: 10.1038/nature10600
Khosla S, Farr JN, Kirkland JL. Inhibiting Cellular Senescence: A New Therapeutic Paradigm for Age-Related Osteoporosis. J Clin Endocrinol Metab. 2018;103(4):12821290.
DOI: 10.1210/jc.2017-02694
Farr JN, Xu M, Weivoda MM, Monroe DG, Fraser DG, Onken JL, et al. Targeting cellular senescence prevents age-related bone loss in mice. Nat Med. 2017;23(9):1072–1079.
DOI: 10.1038/nm.4385
Takeuchi S, Takahashi A, Motoi N, Yoshimoto S, Tajima T, Yamakoshi K, et al. Intrinsic cooperation between p16INK4a and p21Waf1/Cip1 in the onset of cellular senescence and tumor suppression in vivo. Cancer Res. 2010;70(22):9381-9390.
DOI: 10.1158/0008-5472.CAN-10-0801
Larsen CJ. PRB, p53, p16INK4a/ARF, sénescence cellulaire et transformation maligne [pRB, p53, p16INK4a, senescence and malignant transformation]. Bull Cancer. 2004;91(5):399-402. French. PMID: 15281278
Faget DV, Ren Q, Stewart SA. Unmasking senescence: context-dependent effects of SASP in cancer. Nat Rev Cancer. 2019;19(8):439-453.
DOI: 10.1038/s41568-019-0156-2
Kang C. Senolytics and Senostatics: A Two-Pronged Approach to Target Cellular Senescence for Delaying Aging and Age-Related Diseases. Mol Cells. 2019;42(12):821827.
Fuhrmann-Stroissnigg H, Ling YY, Zhao J, McGowan SJ, Zhu Y, Brooks RW, et al. Identification of HSP90 inhibitors as a novel class of senolytics. Nat Commun. 2017;8(1):422.
DOI: 10.1038/s41467-017-00314-z
Zhu Y, Doornebal EJ, Pirtskhalava T, Giorgadze N, Wentworth M, Fuhrmann-Stroissnigg H, et al. New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463. Aging (Albany NY). 2017;9(3):955-963.
DOI: 10.18632/aging.101202
Yousefzadeh MJ, Zhu Y, McGowan SJ, Angelini L, Fuhrmann-Stroissnigg H, Xu M, et al. Fisetin is a serotherapeutic that extends health and lifespan. EBioMedicine. 2018;36:18-28.
DOI: 10.1016/j.ebiom.2018.09.015
Zhu Y, Tchkonia T, Fuhrmann-Stroissnigg H, Dai HM, Ling YY, Stout MB, et al. Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of antiapoptotic factors. Aging Cell. 2016;15(3):428-435.
DOI: 10.1111/acel.12445
Chang J, Wang Y, Shao L, Laberge RM, Demaria M, Campisi J, et al. Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice. Nat Med. 2016;22(1):78-83.
DOI: 10.1038/nm.4010
Wang Y, Chang J, Liu X, Zhang X, Zhang S, Zhang X, et al. Discovery of piperlongumine as a potential novel lead for the development of senolytic agents. Aging (Albany NY). 2016;8(11):2915-2926.
DOI: 10.18632/aging.101100
Baar MP, Brandt R, Putavet DA, Klein J, Derks K, Bourgeois B, et al. Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging. Cell. 2017;169(1):132-147.e16.
DOI: 10.1016/j.cell.2017.02.031
Palmer AK, Gustafson B, Kirkland JL, Smith U. Cellular senescence: at the nexus between ageing and diabetes. Diabetología. 2019;62(10):1835-1841.
DOI: 10.1007/s00125-019-4934-x
Farr JN, Fraser DG, Wang H, Jaehn K, Ogrodnik MB, Weivoda MM, et al. Identification of Senescent Cells in the Bone Microenvironment. J Bone Miner Res. 2016;31(11):19201929.
DOI: 10.1002/jbmr.2892
Xu M, Tchkonia T, Ding H, Ogrodnik M, Lubbers ER, Pirtskhalava T, et al. JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age. Proc Natl Acad Sci U S A. 2015;112(46):E6301-E6310.
DOI: 10.1073/pnas.1515386112
Misra J, Mohanty ST, Madan S, Fernandes JA, Hal Ebetino F, Russell RG, et al. Zoledronate Attenuates Accumulation of DNA Damage in Mesenchymal Stem Cells and Protects Their Function. Stem Cells. 2016;34(3):756-767.
DOI: 10.1002/stem.2255
Lyles KW, Colón-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, et al; HORIZON Recurrent Fracture Trial. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med. 2007;357(18):1799-1809.
DOI: 10.1056/NEJMoa074941
Reid IR, Horne AM, Milhov B, Stewart A, Garratt E, Bastin S, et al. Effects of Zoledronate on Cancer, Cardiac Events, and Mortality in Osteopenic Older Women. J Bone Miner Res. 2020;35(1):20-27.
DOI: 10.1002/jbmr.3860
Marie PJ. Bone cell senescence: mechanisms and perspectives. J Bone Miner Res. 2014;29(6):1311-1321.
DOI: 10.1002/jbmr.2190
Marie PJ, Cohen-Solal M. The Expanding Life and Functions of Osteogenic Cells: From Simple Bone-Making Cells to Multifunctional Cells and Beyond. J Bone Miner Res. 2018;33(2):199-210.
DOI: 10.1002/jbmr.3356
Reid IR, Horne AM, Mihov B, Stewart A, Garratt E, Wong S, et al. Fracture Prevention with Zoledronate in Older Women with Osteopenia. N Engl J Med. 2018;379(25):24072416.
DOI: 10.1056/NEJMoa1808082
Xu M, Pirtskhalava T, Farr JN, Weigand BM, Palmer AK, Weivoda MM, et al. Senolytics improve physical function and increase lifespan in old age. Nat Med. 2018;24(8):12461256.
DOI: 10.1038/s41591-018-0092-9
González-Gualda E, Baker A G, Fruk L, Muñoz-Espín D. A guide to assessing cellular senescence in vitro and in vivo. FEBS J. 2021;288(2) 56-80.
DOI: 10.1111/febs.15570
Sun J, Li Y, Yang X, Dong W, Yang J, Hu Q, et al. Growth differentiation factor 11 accelerates liver senescence through the inhibition of autophagy. Aging Cell. 2022;21:e13532.
DOI: 10.1111/acel.13532